PHEBURANE

Serial Number 79117600
Registration 4281315
706

Registration Progress

Application Filed
Jun 5, 2012
Under Examination
Approved for Publication
Oct 24, 2012
Published for Opposition
Nov 13, 2012
Registered
Jan 29, 2013

Trademark Image

PHEBURANE

Basic Information

Serial Number
79117600
Registration Number
4281315
Filing Date
June 5, 2012
Registration Date
January 29, 2013
Published for Opposition
November 13, 2012
Drawing Code
4

Status Summary

Current Status
Active
Status Code
706
Status Date
Aug 11, 2023
Registration
Registered
Classes
005

Rights Holder

MPerium B.V.

16
Address
Trapgans 5
NL-1244 RL Ankeveen
NL

Ownership History

LUCANE PHARMA

Original Applicant
99
FR

LUCANE PHARMA

Owner at Publication
99
FR

LUCANE PHARMA

Original Registrant
99
PARIS FR

MPerium B.V.

New Owner After Registration #1
16
NL

Legal Representation

Attorney
Terrence J. McAllister

USPTO Deadlines

Next Deadline
2594 days remaining
Section 71 Renewal Due (Principal Register 66a) (Based on registration date 20130129)
Due Date
January 29, 2033
Grace Period Ends
July 29, 2033

Application History

34 events
Date Code Type Description Documents
Aug 7, 2025 CHLD M CHANGE OF OWNER RECEIVED FROM IB Loading...
May 27, 2024 INNP P PARTIAL INVALIDATION PROCESSED BY THE IB Loading...
Apr 18, 2024 INPS P PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Loading...
Apr 18, 2024 INPC P INVALIDATION PROCESSED Loading...
Apr 11, 2024 INPR P PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Loading...
Aug 11, 2023 NA71 E NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Loading...
Aug 11, 2023 71AG O REGISTERED-SEC.71 ACCEPTED Loading...
Aug 11, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 26, 2023 ES71 I TEAS SECTION 71 RECEIVED Loading...
Jul 16, 2022 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Jul 15, 2022 RNWL P INTERNATIONAL REGISTRATION RENEWED Loading...
Jan 29, 2022 REM4 E COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Loading...
Jun 12, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Nov 29, 2018 NA71 E NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Loading...
Nov 29, 2018 71AG O REGISTERED-SEC.71 ACCEPTED Loading...
Nov 29, 2018 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 4, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 4, 2018 ES71 I TEAS SECTION 71 RECEIVED Loading...
Apr 28, 2013 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Mar 8, 2013 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Mar 8, 2013 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 28, 2013 GPAR P GRANT OF PROTECTION CREATED, TO BE SENT TO IB Loading...
Jan 29, 2013 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 23, 2012 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Nov 13, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 31, 2012 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 31, 2012 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Oct 24, 2012 NPUB O NOTICE OF PUBLICATION Loading...
Oct 5, 2012 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 2, 2012 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 1, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 1, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 28, 2012 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Sep 27, 2012 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations intended to treat rare diseases, namely, urea cycle disorders [, organic acidurias, spinal muscular atrophy, Huntington's disease, tuberculosis, amyotrophic lateral sclerosis, lymphoma, leukemia, maple syrup urine disease, thalassemia, sickle cell disease cystic fibrosis, alpha-1 antitrypsine deficiency ]

Classification

International Classes
005